[Morning session on the third day of the 2026 National Talks: Representatives from InnoCare, China Resources Shuanghe, Merck, CDT, Chia Tai Tianqing, AbbVie and other companies attended] September 7th, at about 8:00 today, the 2026 National Basic Medical Insurance Drug List Negotiation Bidding and Commercial Insurance Innovative Drug List Price Agreement The morning session on the third day of the trade officially opened. Reporters observed at the scene that representatives from nearly 20 companies, including China Resources Double-Crane, Merck & Co., Yuanda Pharmaceuticals, Capital Pharmaceutical Holdings, Sino-American Huadong, Chia Tai Tianqing, AbbVie, and Novartis, entered the venue one after another. There are still many oncology drugs under negotiation today. (Reporters Lu Afeng and Yu Miao)